eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | pancytopenia |
| Symptom | C0040034|thrombocytopenia |
| Sentences | 6 |
| PubMedID- 23690288 | Pathophysiology and management of thrombocytopenia in bone marrow failure: possible clinical applications of tpo receptor agonists in aplastic anemia and myelodysplastic syndromes. |
| PubMedID- 21316823 | Platelet transfusions are mainly used for patients with thrombocytopenia due to bone marrow failure, especially cancer patients developing severe chemotherapy-induced thrombocytopenia (e.g. |
| PubMedID- 21327404 | Increased requirement for platelet transfusions concurrent with enhanced bleeding during romiplostim treatment in a patient with thrombocytopenia due to bone marrow failure. |
| PubMedID- 24778999 | Organ infiltration by mc may lead not only to organomegaly, but also to impairment or even loss of organ function and in severe (high grade) disease, bone marrow failure with anemia, thrombocytopenia, and/or recurrent infections (due to neutropenia) may occur. |
| PubMedID- 24273485 | Larger groups in need are patients with myelodysplastic syndrome, chemotherapy-induced thrombocytopenia, other forms of hereditary and acquired bone marrow failure, hepatitis c infections, or liver cirrhosis. |
| PubMedID- 23284257 | (7,8) this is achieved in transfusion medicine using platelet concentrates (pcs), which allow the infusion of large quantities of platelets in small volumes of fluid; this is especially indicated for thrombocytopenia due to bone marrow failure. |
Page: 1